Flying L Partners
Overview
Flying L Partners is a partnership formed by trusted colleagues with a track record of bringing meaningful innovation to the ophthalmic sector and creating value for investors . The firm identifies promising opportunities and raises capital specifically to invest in them . Flying L Partners actively engages with its portfolio companies to accelerate progress with a tight focus on innovation .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Oyster Point Medical LLC | Feb 2019 | Series B | Lead |
| CorneaGen | Oct 2019 | Series B | Lead |
| Newton | Mar 2020 | Series D | Lead |
| Surface Ophthalmics | May 2018 | Series A | Lead |
| TearClear | Aug 2020 | Series B | - |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Flying L Partners based?
Flying L Partners is headquartered in Steamboat Springs, Colorado, United States.
When was Flying L Partners founded?
Flying L Partners was founded in 2016.
How many portfolio companies does Flying L Partners have?
Flying L Partners has 6 portfolio companies in Caplight's dataset.
What are some companies in Flying L Partners's portfolio?
Portfolio companies visible on Caplight include Oyster Point Medical LLC, CorneaGen, Newton, Surface Ophthalmics, TearClear.
What was Flying L Partners's most recent investment shown here?
Flying L Partners's most recent investment in this portfolio sample was in TearClear in 2020.
What sectors does Flying L Partners focus on?
Flying L Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Flying L Partners focus on?
Flying L Partners typically invests at the Mid stage.
What is Flying L Partners's AUM?
Flying L Partners's assets under management are estimated between $0.0 and $50.0M.